Pain
📧 Sign up to get email alerts when something new happens for Pain.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-07-09FDA Approved: TRAMADOL HYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (Trigen Laboratories, LLC)
The FDA approved a supplemental application for Tramadol Hydrochloride Extended-Release from Trigen Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2015-07-09Clinical Trial Update: Comparative Bioavailability of Dexketoprofen Trometamol Oral Solution vs Tablet Formulations [Phase 1]
Phase 1 study comparing the bioavailability of dexketoprofen trometamol when given as an oral solution versus tablet formulations in acute p…
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: NORSPAN Transdermal Patches Phase III Study In Non-Cancer Pain [Phase 3]
Phase III trial update for NORSPAN transdermal fentanyl patches in non-cancer pain has completed the study in patients with pain associated …
-
FDA approval · 2015-06-26FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for methadone hydrochloride (generic) manufactured by VistaPharm, LLC.
-
FDA approval · 2015-06-26FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for methadone hydrochloride by Ascend Laboratories, LLC, confirming regulatory approval for chan…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-06-26FDA Approved: OXYCONTIN — Supplemental Application (Purdue Pharma LP)
FDA approved a supplemental application for OxyContin (oxycodone hydrochloride) submitted by Purdue Pharma LP. The approval pertained to mod…
-
FDA approval · 2015-06-26FDA Approved: HYDROMORPHONE HYDROCHLORIDE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for Hydromorphone Hydrochloride from Padagis US LLC under ANDA 204278. Hydromorphone hydrochloride i…
-
FDA approval · 2015-06-26FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for methadone hydrochloride from SpecGx LLC, enabling the marketing of a generic methadone hydrochlo…
-
FDA approval · 2015-06-26FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Methadone Hydrochloride from Hikma Pharmaceuticals USA Inc., enabling a generic methadone hy…
-
FDA approval · 2015-06-26FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Methadone Hydrochloride by Hikma Pharmaceuticals USA Inc., authorizing a change to the approved …
-
FDA approval · 2015-06-26FDA Approved: FENTANYL TRANSDERMAL — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for fentanyl transdermal submitted by SpecGx LLC.
-
FDA approval · 2015-06-26FDA Approved: FENTANYL — Supplemental Application (Aveva Drug Delivery Systems Inc.)
FDA approved a supplemental application for fentanyl submitted by Aveva Drug Delivery Systems Inc., under ANDA 077449.
-
CLINICAL_TRIALS trial_result · 2015-06-22Clinical Trial Update: Tapentadol in Chronic Malignant Tumour Related Pain [Phase 3]
Phase 3 trial for tapentadol in cancer-related chronic malignant tumour pain was terminated; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-06-19Clinical Trial Update: An Effectiveness and Safety Study of Acetaminophen 1000 mg and Ibuprofen 400 mg in Postoperative Dental Pain. [Phase 4]
Phase 4 study assessing the effectiveness and safety of acetaminophen 1000 mg combined with ibuprofen 400 mg for postoperative dental pain.
-
CLINICAL_TRIALS trial_result · 2015-06-16Clinical Trial Update: Use of Fentanyl Patch in Partial Doses Than the Original [NA]
This update discusses using fentanyl transdermal patches in partial doses compared with the original dosing for chronic pain. The trial stat…
-
FDA approval · 2015-06-11FDA Approved: FENTANYL TRANSDERMAL — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for Fentanyl Transdermal filed by SpecGx LLC.
-
FDA approval · 2015-06-10FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Original Application (Advagen Pharma Ltd)
FDA approved Advagen Pharma Ltd's original application for buprenorphine hydrochloride, authorizing a generic product of buprenorphine for a…
-
FDA approval · 2015-06-04FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for methadone hydrochloride (generic methadone HCl) from Ascend Laboratories, LLC. The approval cove…
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Efficacy of Pain Neurophysiology Education in Combination With Psychologic Inoculation in Chronic Whiplash [EARLY_Phase 1]
This document is an update on a clinical trial evaluating the efficacy of combining pain neurophysiology education with psychological inocul…
-
CLINICAL_TRIALS research · 2015-06-03Clinical Trial Update: Existential Genomics: Effects of Multimodal Rehabilitation and Integrative Care on Patients With Chronic Pain
An entry describing a clinical trial investigating multimodal rehabilitation and integrative care for chronic pain, with the current status …
-
FDA approval · 2015-06-01FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for methadone hydrochloride from SpecGx LLC under an ANDA, indicating an updated/added approval for …
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Urgent Medical and Surgical Conditions During Flights
Clinical trial NCT02457455 investigating urgent medical and surgical conditions during flights has completed, examining scenarios such as sy…
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Web-based CBT for Children With Chronic Pain [Phase 2]
Phase 2 trial of web-based cognitive behavioral therapy for children with chronic pain has completed. The study included children with chron…
-
CLINICAL_TRIALS research · 2015-05-27Clinical Trial Update: Ultra-low Dose Oral Ketamine for Chronic Pain in the Primary Care Setting [Phase 3]
Phase 3 clinical trial evaluating ultra-low dose oral ketamine for chronic pain in a primary care setting; current status is UNKNOWN.
-
CLINICAL_TRIALS research · 2015-05-21Clinical Trial Update: Translation of the Self Completed-Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale
Clinical trial update describing the translation of the Self Completed-Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale for use…